The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can exercise melt away liver fat? Results expected Sep 2026 (estimated)
- New drug aims to help patients shed pounds after failed weight-loss surgery Results expected Nov 2026 (estimated)
- Robot takes the strain out of gallstone surgery Results expected Dec 2026 (estimated)
- Could belly fat help fix infertility? new trial tests fat cells to thicken uterine lining Results expected Dec 2026 (estimated)
- Psoriasis patients: does your injection schedule matter? Results expected Dec 2026 (estimated)
-
Could common diabetes drugs reverse early memory loss?
Disease control CompletedThis study tests whether three diabetes medications—liraglutide, empagliflozin, and linagliptin—can help reverse mild cognitive impairment (early memory and thinking problems) in people with type 2 diabetes. About 396 participants will take one of the drugs for 48 weeks, with an …
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a diabetes drug boost weight loss after surgery?
Disease control CompletedThis study looked at whether liraglutide, a drug used for diabetes and weight loss, can help people who are still obese 6 months after metabolic surgery lose more weight. 100 participants received liraglutide injections for 24 weeks along with diet and exercise guidance. The goal…
Phase 4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for Hard-to-Control blood pressure: finerenone shows promise
Disease control CompletedThis study tested a drug called finerenone in 55 adults with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, leading to high blood pressure. The goal was to see if finerenone can safely lower blood pressure over 12 weeks. Participants starte…
Phase 4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 26, 2026 16:02 UTC
-
Spit test aims to spot Sjögren's disease without a biopsy
Diagnosis CompletedResearchers are studying whether cell-free RNA in saliva can work as a non-invasive liquid biopsy to help diagnose Sjögren's disease. The trial compares saliva from people with Sjögren's disease against saliva from people with dry-eye and dry-mouth symptoms who do not have the di…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
10,000 seniors studied to predict fatty liver dangers
Knowledge-focused CompletedThis study looked at 10,000 older adults (age 60+) with fatty liver disease to find out what increases their risk for serious liver problems like scarring, cirrhosis, or liver cancer. Researchers used medical records and yearly check-ups to build a computer model that predicts th…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC